Access cutting-edge osteogenic sarcoma treatment through this clinical trial at a research site in Houston. Study-provided care at no cost to qualified participants.
Access osteogenic sarcoma specialists in Houston at no cost
This study follows strict safety protocols and ethical guidelines
All study-related osteogenic sarcoma treatment provided free
This will be a phase II, single arm study of osteosarcoma patients with fully resected pulmonary metastases. The MTD corresponds to the dosage recommendations of the manufacturer of Iscador® P which is licensed in Sweden, New Zealand, South Korea, Germany and Switzerland for the treatment of solid tumors and precancerous lesions. The study population includes patients with relapse of osteosarcoma in the lung following surgical resection of all gross disease (2nd or greater CR). Following comple
Sponsor: Hackensack Meridian Health
Check if you qualify for this osteogenic sarcoma clinical trial in Houston, TX
If you're searching for osteogenic sarcoma treatment options in Houston, TX, this clinical trial may be an excellent opportunity. Clinical trials provide access to cutting-edge treatments that aren't yet available to the general public, often at no cost to participants.
Our Houston research site is actively enrolling participants for this clinical trial. You'll receive care from experienced osteogenic sarcoma specialists who are at the forefront of medical research. All study-related care, including examinations, treatments, and monitoring, is provided at no cost to qualified participants.